Adjunctive Medical Therapy for Acromegalic Patients /:
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Berlin ; Boston :
De Gruyter Mouton,
[2019]
|
| Ausgabe: | Reprint 2019. |
| Schriftenreihe: | Clinical research series ;
2 |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | 1 online resource (x, 91 pages) : Num. tables |
| ISBN: | 3110851725 9783110851724 |
Internformat
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-on1125188447 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 191022s2019 gw od z000 0 eng d | ||
| 040 | |a DEGRU |b eng |e rda |e pn |c DEGRU |d N$T |d OCLCQ |d OCLCF |d OCLCO |d OCLCQ |d DEGRU |d OCLCO |d OCLCL |d TMA |d OCLCQ | ||
| 020 | |a 3110851725 | ||
| 020 | |a 9783110851724 |q (electronic bk.) | ||
| 024 | 7 | |a 10.1515/9783110851724 |2 doi | |
| 035 | |a (OCoLC)1125188447 | ||
| 050 | 4 | |a RC658.3 | |
| 072 | 7 | |a MED027000 |2 bisacsh | |
| 082 | 7 | |a 616.47 |2 23 | |
| 049 | |a MAIN | ||
| 100 | 1 | |a Nortier, J. W. R., |e author. |0 http://id.loc.gov/authorities/names/n85387340 | |
| 245 | 1 | 0 | |a Adjunctive Medical Therapy for Acromegalic Patients / |c J.W.R. Nortier. |
| 250 | |a Reprint 2019. | ||
| 264 | 1 | |a Berlin ; |a Boston : |b De Gruyter Mouton, |c [2019] | |
| 264 | 4 | |c ©1984 | |
| 300 | |a 1 online resource (x, 91 pages) : |b Num. tables | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a text file |b PDF |2 rda | ||
| 490 | 0 | |a Clinical research series ; |v 2 | |
| 505 | 0 | 0 | |t Frontmatter -- |t List of abbreviations -- |t Contents -- |t CHAPTER I. Introduction -- |t CHAPTER II. Plasma growth hormone suppressive effect of bromocriptine in acromegaly. Evaluation by plasma GH day profiles and plasma GH concentrations during oral glucose tolerance tests / |r Nortier, J.W.R. / Croughs, R.J.M. / Thijssen, J.H.H. / Schwarz, F. -- |t CHAPTER III. Changes in plasma GH levels and clinical activity during bromocriptine therapy in acromegaly. The value of predictive tests / |r Nortier, J.W.R. / Croughs, R.J.M. / Donker, G.H. / Thijssen, J.H.H. / Schwarz, F. -- |t CHAPTER IV. Bromocriptine therapy in acromegaly: effects on plasma GH levels, somatomedin-C levels and clinical activity / |r Nortier, J.W.R. / Croughs, R.J.M. / Thijssen, J.H.H. / Schwarz, F. -- |t CHAPTER V. Gel filtration studies of plasma growth hormone in bromocriptine treated acromegaly: correlations with somatomedin-C and clinical response / |r Nortier, J.W.R. / Croughs, R.J.M. / Donker, G.H. / Thijssen, J.H.H. / Schwarz, F. -- |t CHAPTER VI. No acute effect of pimozide on the plasma GH levels in acromegaly / |r Nortier, J.W.R. / Croughs, R.J.M. / Donker, G.H. / Thijssen, J.H.H. / Schwarz, F. -- |t CHAPTER VII. Long-term follow-up of five untreated acromegalic patients / |r Nortier, J.W.R. / Croughs, R.J.M. / Thijssen, J.H.H. / Schwarz, F. -- |t CHAPTER VIII. General discussion -- |t Summary |
| 546 | |a In English. | ||
| 588 | 0 | |a Online resource; title from PDF title page (publisher's Web site, viewed 22. Okt 2019). | |
| 650 | 0 | |a Acromegaly. |0 http://id.loc.gov/authorities/subjects/sh85000666 | |
| 650 | 0 | |a Bromocriptine |x Therapeutic use. | |
| 650 | 0 | |a Somatotropin. |0 http://id.loc.gov/authorities/subjects/sh85124783 | |
| 650 | 2 | |a Acromegaly |0 https://id.nlm.nih.gov/mesh/D000172 | |
| 650 | 2 | |a Growth Hormone |0 https://id.nlm.nih.gov/mesh/D013006 | |
| 650 | 6 | |a Acromégalie. | |
| 650 | 6 | |a Bromocriptine |x Emploi en thérapeutique. | |
| 650 | 6 | |a Somatotrophine. | |
| 650 | 7 | |a MEDICAL |x Endocrinology & Metabolism. |2 bisacsh | |
| 650 | 7 | |a Acromegaly |2 fast | |
| 650 | 7 | |a Somatotropin |2 fast | |
| 776 | 0 | 8 | |i Print version: |z 9783110133653 |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2266610 |3 Volltext |
| 936 | |a BATCHLOAD | ||
| 938 | |a De Gruyter |b DEGR |n 9783110851724 | ||
| 938 | |a EBSCOhost |b EBSC |n 2266610 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-on1125188447 |
|---|---|
| _version_ | 1816882503968882688 |
| adam_text | |
| any_adam_object | |
| author | Nortier, J. W. R. |
| author_GND | http://id.loc.gov/authorities/names/n85387340 |
| author_additional | Nortier, J.W.R. / Croughs, R.J.M. / Thijssen, J.H.H. / Schwarz, F. -- Nortier, J.W.R. / Croughs, R.J.M. / Donker, G.H. / Thijssen, J.H.H. / Schwarz, F. -- |
| author_facet | Nortier, J. W. R. |
| author_role | aut |
| author_sort | Nortier, J. W. R. |
| author_variant | j w r n jwr jwrn |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | RC658 |
| callnumber-raw | RC658.3 |
| callnumber-search | RC658.3 |
| callnumber-sort | RC 3658.3 |
| callnumber-subject | RC - Internal Medicine |
| collection | ZDB-4-EBA |
| contents | Frontmatter -- List of abbreviations -- Contents -- CHAPTER I. Introduction -- CHAPTER II. Plasma growth hormone suppressive effect of bromocriptine in acromegaly. Evaluation by plasma GH day profiles and plasma GH concentrations during oral glucose tolerance tests / CHAPTER III. Changes in plasma GH levels and clinical activity during bromocriptine therapy in acromegaly. The value of predictive tests / CHAPTER IV. Bromocriptine therapy in acromegaly: effects on plasma GH levels, somatomedin-C levels and clinical activity / CHAPTER V. Gel filtration studies of plasma growth hormone in bromocriptine treated acromegaly: correlations with somatomedin-C and clinical response / CHAPTER VI. No acute effect of pimozide on the plasma GH levels in acromegaly / CHAPTER VII. Long-term follow-up of five untreated acromegalic patients / CHAPTER VIII. General discussion -- Summary |
| ctrlnum | (OCoLC)1125188447 |
| dewey-full | 616.47 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.47 |
| dewey-search | 616.47 |
| dewey-sort | 3616.47 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | Reprint 2019. |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03527cam a2200577 i 4500</leader><controlfield tag="001">ZDB-4-EBA-on1125188447</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">191022s2019 gw od z000 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DEGRU</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">DEGRU</subfield><subfield code="d">N$T</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">DEGRU</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield><subfield code="d">TMA</subfield><subfield code="d">OCLCQ</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3110851725</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783110851724</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1515/9783110851724</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1125188447</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC658.3</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED027000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">616.47</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Nortier, J. W. R.,</subfield><subfield code="e">author.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n85387340</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Adjunctive Medical Therapy for Acromegalic Patients /</subfield><subfield code="c">J.W.R. Nortier.</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">Reprint 2019.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin ;</subfield><subfield code="a">Boston :</subfield><subfield code="b">De Gruyter Mouton,</subfield><subfield code="c">[2019]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©1984</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (x, 91 pages) :</subfield><subfield code="b">Num. tables</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="a">text file</subfield><subfield code="b">PDF</subfield><subfield code="2">rda</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Clinical research series ;</subfield><subfield code="v">2</subfield></datafield><datafield tag="505" ind1="0" ind2="0"><subfield code="t">Frontmatter --</subfield><subfield code="t">List of abbreviations --</subfield><subfield code="t">Contents --</subfield><subfield code="t">CHAPTER I. Introduction --</subfield><subfield code="t">CHAPTER II. Plasma growth hormone suppressive effect of bromocriptine in acromegaly. Evaluation by plasma GH day profiles and plasma GH concentrations during oral glucose tolerance tests /</subfield><subfield code="r">Nortier, J.W.R. / Croughs, R.J.M. / Thijssen, J.H.H. / Schwarz, F. --</subfield><subfield code="t">CHAPTER III. Changes in plasma GH levels and clinical activity during bromocriptine therapy in acromegaly. The value of predictive tests /</subfield><subfield code="r">Nortier, J.W.R. / Croughs, R.J.M. / Donker, G.H. / Thijssen, J.H.H. / Schwarz, F. --</subfield><subfield code="t">CHAPTER IV. Bromocriptine therapy in acromegaly: effects on plasma GH levels, somatomedin-C levels and clinical activity /</subfield><subfield code="r">Nortier, J.W.R. / Croughs, R.J.M. / Thijssen, J.H.H. / Schwarz, F. --</subfield><subfield code="t">CHAPTER V. Gel filtration studies of plasma growth hormone in bromocriptine treated acromegaly: correlations with somatomedin-C and clinical response /</subfield><subfield code="r">Nortier, J.W.R. / Croughs, R.J.M. / Donker, G.H. / Thijssen, J.H.H. / Schwarz, F. --</subfield><subfield code="t">CHAPTER VI. No acute effect of pimozide on the plasma GH levels in acromegaly /</subfield><subfield code="r">Nortier, J.W.R. / Croughs, R.J.M. / Donker, G.H. / Thijssen, J.H.H. / Schwarz, F. --</subfield><subfield code="t">CHAPTER VII. Long-term follow-up of five untreated acromegalic patients /</subfield><subfield code="r">Nortier, J.W.R. / Croughs, R.J.M. / Thijssen, J.H.H. / Schwarz, F. --</subfield><subfield code="t">CHAPTER VIII. General discussion --</subfield><subfield code="t">Summary</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">In English.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Online resource; title from PDF title page (publisher's Web site, viewed 22. Okt 2019).</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Acromegaly.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85000666</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Bromocriptine</subfield><subfield code="x">Therapeutic use.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Somatotropin.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85124783</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Acromegaly</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D000172</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Growth Hormone</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D013006</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Acromégalie.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Bromocriptine</subfield><subfield code="x">Emploi en thérapeutique.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Somatotrophine.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Endocrinology & Metabolism.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Acromegaly</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Somatotropin</subfield><subfield code="2">fast</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="z">9783110133653</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2266610</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="936" ind1=" " ind2=" "><subfield code="a">BATCHLOAD</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">De Gruyter</subfield><subfield code="b">DEGR</subfield><subfield code="n">9783110851724</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">2266610</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| id | ZDB-4-EBA-on1125188447 |
| illustrated | Not Illustrated |
| indexdate | 2024-11-27T13:29:39Z |
| institution | BVB |
| isbn | 3110851725 9783110851724 |
| language | English |
| oclc_num | 1125188447 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource (x, 91 pages) : Num. tables |
| psigel | ZDB-4-EBA |
| publishDate | 2019 |
| publishDateSearch | 2019 |
| publishDateSort | 2019 |
| publisher | De Gruyter Mouton, |
| record_format | marc |
| series2 | Clinical research series ; |
| spelling | Nortier, J. W. R., author. http://id.loc.gov/authorities/names/n85387340 Adjunctive Medical Therapy for Acromegalic Patients / J.W.R. Nortier. Reprint 2019. Berlin ; Boston : De Gruyter Mouton, [2019] ©1984 1 online resource (x, 91 pages) : Num. tables text txt rdacontent computer c rdamedia online resource cr rdacarrier text file PDF rda Clinical research series ; 2 Frontmatter -- List of abbreviations -- Contents -- CHAPTER I. Introduction -- CHAPTER II. Plasma growth hormone suppressive effect of bromocriptine in acromegaly. Evaluation by plasma GH day profiles and plasma GH concentrations during oral glucose tolerance tests / Nortier, J.W.R. / Croughs, R.J.M. / Thijssen, J.H.H. / Schwarz, F. -- CHAPTER III. Changes in plasma GH levels and clinical activity during bromocriptine therapy in acromegaly. The value of predictive tests / Nortier, J.W.R. / Croughs, R.J.M. / Donker, G.H. / Thijssen, J.H.H. / Schwarz, F. -- CHAPTER IV. Bromocriptine therapy in acromegaly: effects on plasma GH levels, somatomedin-C levels and clinical activity / Nortier, J.W.R. / Croughs, R.J.M. / Thijssen, J.H.H. / Schwarz, F. -- CHAPTER V. Gel filtration studies of plasma growth hormone in bromocriptine treated acromegaly: correlations with somatomedin-C and clinical response / Nortier, J.W.R. / Croughs, R.J.M. / Donker, G.H. / Thijssen, J.H.H. / Schwarz, F. -- CHAPTER VI. No acute effect of pimozide on the plasma GH levels in acromegaly / Nortier, J.W.R. / Croughs, R.J.M. / Donker, G.H. / Thijssen, J.H.H. / Schwarz, F. -- CHAPTER VII. Long-term follow-up of five untreated acromegalic patients / Nortier, J.W.R. / Croughs, R.J.M. / Thijssen, J.H.H. / Schwarz, F. -- CHAPTER VIII. General discussion -- Summary In English. Online resource; title from PDF title page (publisher's Web site, viewed 22. Okt 2019). Acromegaly. http://id.loc.gov/authorities/subjects/sh85000666 Bromocriptine Therapeutic use. Somatotropin. http://id.loc.gov/authorities/subjects/sh85124783 Acromegaly https://id.nlm.nih.gov/mesh/D000172 Growth Hormone https://id.nlm.nih.gov/mesh/D013006 Acromégalie. Bromocriptine Emploi en thérapeutique. Somatotrophine. MEDICAL Endocrinology & Metabolism. bisacsh Acromegaly fast Somatotropin fast Print version: 9783110133653 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2266610 Volltext |
| spellingShingle | Nortier, J. W. R. Adjunctive Medical Therapy for Acromegalic Patients / Frontmatter -- List of abbreviations -- Contents -- CHAPTER I. Introduction -- CHAPTER II. Plasma growth hormone suppressive effect of bromocriptine in acromegaly. Evaluation by plasma GH day profiles and plasma GH concentrations during oral glucose tolerance tests / CHAPTER III. Changes in plasma GH levels and clinical activity during bromocriptine therapy in acromegaly. The value of predictive tests / CHAPTER IV. Bromocriptine therapy in acromegaly: effects on plasma GH levels, somatomedin-C levels and clinical activity / CHAPTER V. Gel filtration studies of plasma growth hormone in bromocriptine treated acromegaly: correlations with somatomedin-C and clinical response / CHAPTER VI. No acute effect of pimozide on the plasma GH levels in acromegaly / CHAPTER VII. Long-term follow-up of five untreated acromegalic patients / CHAPTER VIII. General discussion -- Summary Acromegaly. http://id.loc.gov/authorities/subjects/sh85000666 Bromocriptine Therapeutic use. Somatotropin. http://id.loc.gov/authorities/subjects/sh85124783 Acromegaly https://id.nlm.nih.gov/mesh/D000172 Growth Hormone https://id.nlm.nih.gov/mesh/D013006 Acromégalie. Bromocriptine Emploi en thérapeutique. Somatotrophine. MEDICAL Endocrinology & Metabolism. bisacsh Acromegaly fast Somatotropin fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85000666 http://id.loc.gov/authorities/subjects/sh85124783 https://id.nlm.nih.gov/mesh/D000172 https://id.nlm.nih.gov/mesh/D013006 |
| title | Adjunctive Medical Therapy for Acromegalic Patients / |
| title_alt | Frontmatter -- List of abbreviations -- Contents -- CHAPTER I. Introduction -- CHAPTER II. Plasma growth hormone suppressive effect of bromocriptine in acromegaly. Evaluation by plasma GH day profiles and plasma GH concentrations during oral glucose tolerance tests / CHAPTER III. Changes in plasma GH levels and clinical activity during bromocriptine therapy in acromegaly. The value of predictive tests / CHAPTER IV. Bromocriptine therapy in acromegaly: effects on plasma GH levels, somatomedin-C levels and clinical activity / CHAPTER V. Gel filtration studies of plasma growth hormone in bromocriptine treated acromegaly: correlations with somatomedin-C and clinical response / CHAPTER VI. No acute effect of pimozide on the plasma GH levels in acromegaly / CHAPTER VII. Long-term follow-up of five untreated acromegalic patients / CHAPTER VIII. General discussion -- Summary |
| title_auth | Adjunctive Medical Therapy for Acromegalic Patients / |
| title_exact_search | Adjunctive Medical Therapy for Acromegalic Patients / |
| title_full | Adjunctive Medical Therapy for Acromegalic Patients / J.W.R. Nortier. |
| title_fullStr | Adjunctive Medical Therapy for Acromegalic Patients / J.W.R. Nortier. |
| title_full_unstemmed | Adjunctive Medical Therapy for Acromegalic Patients / J.W.R. Nortier. |
| title_short | Adjunctive Medical Therapy for Acromegalic Patients / |
| title_sort | adjunctive medical therapy for acromegalic patients |
| topic | Acromegaly. http://id.loc.gov/authorities/subjects/sh85000666 Bromocriptine Therapeutic use. Somatotropin. http://id.loc.gov/authorities/subjects/sh85124783 Acromegaly https://id.nlm.nih.gov/mesh/D000172 Growth Hormone https://id.nlm.nih.gov/mesh/D013006 Acromégalie. Bromocriptine Emploi en thérapeutique. Somatotrophine. MEDICAL Endocrinology & Metabolism. bisacsh Acromegaly fast Somatotropin fast |
| topic_facet | Acromegaly. Bromocriptine Therapeutic use. Somatotropin. Acromegaly Growth Hormone Acromégalie. Bromocriptine Emploi en thérapeutique. Somatotrophine. MEDICAL Endocrinology & Metabolism. Somatotropin |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2266610 |
| work_keys_str_mv | AT nortierjwr adjunctivemedicaltherapyforacromegalicpatients |